Viswanathan Ravi
SEC-identified person · CIK 1479386 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Duolingo, Inc. DUOL | Officer | filed 2021 - 2022 |
| Phasebio Pharmaceuticals Inc PHAS | Officer | filed 2018 - 2018 |
| Tapimmune INC. TPIV.OB | Officer | filed 2018 - 2018 |
| Elastic N.V. ESTC | Officer | filed 2018 - 2018 |
| Adaptimmune Therapeutics PLC ADAP] | Officer | filed 2016 - 2018 |
| Aveo Pharmaceuticals, INC. AVEO | Officer | filed 2016 - 2018 |
| Ardelyx, INC. ARDX | Officer | filed 2015 - 2018 |
| Mulesoft, INC MULE | Officer | filed 2017 - 2018 |
| Surface Oncology, Inc. SURF | Officer | filed 2018 - 2018 |
| Tracon Pharmaceuticals, Inc. TCON | Officer | filed 2015 - 2018 |
| Oncothyreon Inc. ONTY | Officer | filed 2017 - 2018 |
| Tesaro, Inc. TSRO | Officer | filed 2012 - 2018 |
| Oruka Therapeutics, Inc. ORKA | Officer | filed 2015 - 2018 |
| Ra Pharmaceuticals, Inc. RARX | Officer | filed 2016 - 2018 |
| Appian Corp APPN | Officer | filed 2017 - 2018 |
| Synlogic, INC. SYBX | Officer | filed 2015 - 2018 |
| Genocea Biosciences, INC. GNCA | Officer | filed 2018 - 2018 |
| Strongbridge Biopharma plc SBBP | Officer | filed 2018 - 2018 |
| X4 Pharmaceuticals, Inc XFOR | Officer | filed 2017 - 2017 |
| Care.com Inc CRCM | Officer | filed 2014 - 2017 |
| Rhythm Pharmaceuticals, INC. SRYTM | Officer | filed 2017 - 2017 |
| Regulus Therapeutics Inc. RGLS | Officer | filed 2017 - 2017 |
| Mersana Therapeutics, Inc. [MRSN] | Officer | filed 2017 - 2017 |
| Achaogen, Inc. AKAO | Officer | filed 2016 - 2016 |
| Roka Bioscience, Inc. ROKA | Officer | filed 2014 - 2016 |
| Interleukin Genetics INC ILIU | Officer | filed 2013 - 2016 |
| Epizyme, Inc. EPZM | Officer | filed 2013 - 2016 |
| Cerecor Inc. CERC | Officer | filed 2015 - 2015 |
| Champions Sports INC csbr | Officer | filed 2015 - 2015 |
| BOX INC BOX | Officer | filed 2015 - 2015 |
| Cvent INC CVT | Officer | filed 2013 - 2014 |
| Dermira, Inc. DERM | Officer | filed 2014 - 2014 |
| Loxo Oncology, Inc. LOXO | Officer | filed 2014 - 2014 |
| Aerohive Networks, INC HIVE | Officer | filed 2014 - 2014 |
| Glycomimetics INC GLYC | Officer | filed 2014 - 2014 |
| Omthera Pharmaceuticals, Inc. OMTH | Director | filed 2013 - 2013 |
| Clovis Oncology, Inc. CLVS | Officer | filed 2011 - 2013 |
| Workday, Inc. WDAY | Officer | filed 2012 - 2013 |
| Millennial Media Inc. MM | Officer | filed 2012 - 2012 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.